| 國立成功大學 |
2021 |
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan
|
Huang, K.;Lin, F.-J.;Ou, H.-T.;Hsu, C.-N.;Huang, L.-Y.;Wang, C.-C.;Toh, S. |
| 臺大學術典藏 |
2020-12-29T08:15:44Z |
Loss of Ikbkap/Elp1 in mouse oocytes causes spindle disorganization, developmental defects in preimplantation embryos and impaired female fertility
|
FU-JUNG LIN; Lin, F.-J.; Lee, Y.-J.; Jiang, C.-L.; Yang, K.-T.; Inoue, A.; Yang, K.-T.;Inoue, A.;Lee, Y.-J.;Jiang, C.-L.;Lin, F.-J. |
| 臺大學術典藏 |
2020-12-28T02:40:14Z |
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
|
Shih Y.-R.;Liao K.-H.;Yen-Hui Chen;Lin F.-J.;Hsiao F.-Y.; Shih Y.-R.; Liao K.-H.; YEN-HUI CHEN; Lin F.-J.; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-12-25T08:38:32Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
HSIEN-LI KAO; Wang C.-C.; Lin S.-Y.; Lin F.-J.; Wang Y.-H. |
| 臺大學術典藏 |
2020-12-24T03:00:36Z |
Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
|
Su C.-Y.;Li-Jiuan Shen;Hsieh S.-C.;Lin L.-Y.;Lin F.-J.; Su C.-Y.; LI-JIUAN SHEN; Hsieh S.-C.; Lin L.-Y.; Lin F.-J. |
| 臺大學術典藏 |
2020-12-23T03:35:04Z |
Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan
|
FEI-YUAN HSIAO; Wang T.-D.; Huang S.-T.; Wang C.-Y.; Lin F.-J.; Chen H.-M. |
| 臺大學術典藏 |
2020-12-23T03:35:00Z |
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
|
Shih Y.-R.; Liao K.-H.; Chen Y.-H.; Lin F.-J.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2020-12-16T02:25:19Z |
Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012 Dr. Segolene Ayme
|
Lin H.-Y.;Chuang C.-K.;Huang Y.-H.;Tu R.-Y.;Lin F.-J.;Lin S.J.;Chiu P.C.;Niu D.-M.;Tsai F.-J.;Wuh-Liang Hwu;Chien Y.-H.;Lin J.-L.;Chou Y.-Y.;Tsai W.-H.;Chang T.-M.;Lin S.-P.; Lin H.-Y.; Chuang C.-K.; Huang Y.-H.; Tu R.-Y.; Lin F.-J.; Lin S.J.; Chiu P.C.; Niu D.-M.; Tsai F.-J.; WUH-LIANG HWU; Chien Y.-H.; Lin J.-L.; Chou Y.-Y.; Tsai W.-H.; Chang T.-M.; Lin S.-P. |
| 臺大學術典藏 |
2020-12-04T07:44:33Z |
Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
|
Su C.-Y.; Shen L.-J.; Hsieh S.-C.; LIAN-YU LIN; Lin F.-J. |
| 臺大學術典藏 |
2020-12-01T08:29:00Z |
Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan
|
TZUNG-DAU WANG; Huang S.-T.; Wang C.-Y.; Lin F.-J.; Chen H.-M.; Hsiao F.-Y. |
| 臺大學術典藏 |
2020-11-27T08:14:42Z |
Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition: An experience in Taiwan
|
Chien C.-R.;Chen S.-W.;Chang-Yao Hsieh;Liang J.-A.;Yang S.-N.;Huang C.-Y.;Lin F.-J.; Chien C.-R.; Chen S.-W.; CHANG-YAO HSIEH; Liang J.-A.; Yang S.-N.; Huang C.-Y.; Lin F.-J. |
| 臺大學術典藏 |
2020-11-27T08:14:41Z |
Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: A preliminary report
|
Chien C.-R.;Chen S.-W.;Chang-Yao Hsieh;Liang J.-A.;Yang S.-N.;Huang C.-Y.;Lin F.-J.; Chien C.-R.; Chen S.-W.; CHANG-YAO HSIEH; Liang J.-A.; Yang S.-N.; Huang C.-Y.; Lin F.-J. |
| 臺大學術典藏 |
2020-11-27T03:24:58Z |
A web-based clinical system for cohort surveillance of specific clinical effectiveness and safety outcomes: A cohort study of non-Vitamin K antagonist oral anticoagulants and warfarin
|
Lin F.-C.; Huang S.-T.; Shang R.J.; Wang C.-C.; Hsiao F.-Y.; Lin F.-J.; Lin M.-S.; KUAN-YU HUNG; Wang J.; Shen L.-J.; Lai F.; Huang C.-F. |
| 臺大學術典藏 |
2020-11-03T11:56:54Z |
Blood NfL: A biomarker for disease severity and progression in Parkinson disease
|
Lin C.-H.;Li C.-H.;Yang K.-C.;Lin F.-J.;Wu C.-C.;Chieh J.-J.;Ming-Jang Chiu; Lin C.-H.; Li C.-H.; Yang K.-C.; Lin F.-J.; Wu C.-C.; Chieh J.-J.; MING-JANG CHIU |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators; Ho L.-T.; Lin F.-J. |
| 臺大學術典藏 |
2020-07-24T03:42:43Z |
Factors controlling atmospheric fluxes of Be-7 and Pb-210 in northern Taiwan
|
Su, C. C.;Huh, C. A.;Lin, F. J.; Su, C. C.; Huh, C. A.; Lin, F. J.; CHIH-CHIEH SU |
| 臺大學術典藏 |
2020-06-01T09:06:46Z |
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
|
Heerspink H.J.L.;Karasik A.;Thuresson M.;Melzer-Cohen C.;Chodick G.;Khunti K.;Wilding J.P.H.;Garcia Rodriguez L.A.;Cea-Soriano L.;Kohsaka S.;Nicolucci A.;Lucisano G.;Lin F.-J.;Chih-Yuan Wang;Wittbrodt E.;Fenici P.;Kosiborod M.; Heerspink H.J.L.; Karasik A.; Thuresson M.; Melzer-Cohen C.; Chodick G.; Khunti K.; Wilding J.P.H.; Garcia Rodriguez L.A.; Cea-Soriano L.; Kohsaka S.; Nicolucci A.; Lucisano G.; Lin F.-J.; CHIH-YUAN WANG; Wittbrodt E.; Fenici P.; Kosiborod M. |
| 臺大學術典藏 |
2020-06-01T09:06:45Z |
Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
|
Cheng C.-N.;Chih-Yuan Wang;Lin H.-W.;Chang T.-Y.;Lin H.-J.;Chou C.;Lin F.-J.; Cheng C.-N.; CHIH-YUAN WANG; Lin H.-W.; Chang T.-Y.; Lin H.-J.; Chou C.; Lin F.-J. |
| 臺大學術典藏 |
2020-04-16T02:35:21Z |
Investigation of light scattering characteristics of individual leukocytes using three-dimensional refractive index maps
|
Lin, F.-J.; Hsieh, C.-M.; Wu, S.-J.; KUNG-BIN SUNG; Lin, Y.-H.; Sung, K.-B. |
| 臺大學術典藏 |
2020-04-16T02:34:40Z |
A web-based clinical system for cohort surveillance of specific clinical effectiveness and safety outcomes: A cohort study of non-Vitamin K antagonist oral anticoagulants and warfarin
|
Lin, F.-C.;Huang, S.-T.;Shang, R.J.;Wang, C.-C.;Hsiao, F.-Y.;Lin, F.-J.;Lin, M.-S.;Hung, K.-Y.;Wang, J.;Shen, L.-J.;Lai, F.;Huang, C.-F.; Lin, F.-C.; Huang, S.-T.; Shang, R.J.; Wang, C.-C.; Hsiao, F.-Y.; Lin, F.-J.; Lin, M.-S.; Hung, K.-Y.; Wang, J.; Shen, L.-J.; Lai, F.; Huang, C.-F.; FEI-PEI LAI |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:04Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
